131 related articles for article (PubMed ID: 16391492)
1. Octreotide exerts only acute, but no sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome.
Zomerhuis MT; Hussain SM; Feelders RA; van der Lely AJ; de Herder WW
Neuroendocrinology; 2005; 82(1):41-8. PubMed ID: 16391492
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation.
Cho KJ; Vinik AI
Radiology; 1990 Nov; 177(2):549-53. PubMed ID: 2171015
[TBL] [Abstract][Full Text] [Related]
3. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
Katakami N; Matsumoto H; Ishihara K; Umeda B
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
[TBL] [Abstract][Full Text] [Related]
6. [Liver metastasis from carcinoid: diagnostic imaging].
De Santis M; Santini D; Alborino S; Carubbi F; Romagnoli R
Radiol Med; 1996 Nov; 92(5):594-9. PubMed ID: 9036451
[TBL] [Abstract][Full Text] [Related]
7. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
[TBL] [Abstract][Full Text] [Related]
8. Octreotide in control of multiple liver metastases from gastrinoma.
Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastasized midgut carcinoids with dacarbazine.
Ritzel U; Leonhardt U; Stöckmann F; Ramadori G
Am J Gastroenterol; 1995 Apr; 90(4):627-31. PubMed ID: 7536389
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
[TBL] [Abstract][Full Text] [Related]
11. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
Massimino K; Harrskog O; Pommier S; Pommier R
J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
13. Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
Leong WL; Pasieka JL
J Surg Oncol; 2002 Mar; 79(3):180-7. PubMed ID: 11870669
[TBL] [Abstract][Full Text] [Related]
14. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver.
Bader TR; Semelka RC; Chiu VC; Armao DM; Woosley JT
J Magn Reson Imaging; 2001 Sep; 14(3):261-9. PubMed ID: 11536403
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.
Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O
Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough?
Bhosale P; Kwek JW; Iyer R; Wei W; Bassett R; Kundra V
Neuroendocrinology; 2011; 93(4):241-8. PubMed ID: 21474918
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic, surgical and medical aspect of the midgut carcinoids.
de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic carcinoid tumours with octreotide.
Ozbey N
Int J Clin Pract; 2002 Jun; 56(5):407. PubMed ID: 12137455
[No Abstract] [Full Text] [Related]
[Next] [New Search]